Benjamin Thuma — 12 Patents at Pfizer

Benjamin Thuma has been granted 12 US patents while listed as an inventor at Pfizer. The first was granted in 2009 and the most recent in April 2023. Benjamin Thuma ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Benjamin Thuma in Old Lyme, CT, US.

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11634410	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more	2023-04-25	$397,929,000
10988463	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more	2021-04-27	$1,331,995,000
10851367	Tissue-specific genome engineering using CRISPR-Cas9	Spiros Liras, Vincent Mascitti, Jennifer A. Doudna, Romain Rouet	2020-12-01	$390,003,000
10813942	Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR	Spiros Liras, Vincent Mascitti	2020-10-27	$309,700,000
10787438	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more	2020-09-29	$414,122,000
10376531	Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR	Spiros Liras, Vincent Mascitti	2019-08-13	$821,443,000
10174007	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more	2019-01-08	$262,548,000
10039778	Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR	Spiros Liras, Vincent Mascitti	2018-08-07	$243,216,000
9809579	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more	2017-11-07	$741,555,000
9617293	Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR	Spiros Liras, Vincent Mascitti	2017-04-11	$241,476,000
9340553	Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR	Spiros Liras, Vincent Mascitti	2016-05-17	$431,006,000
7615651	Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof	Roger B. Ruggeri, George T. Magnus-Aryitey	2009-11-10	$1,059,216,000

Benjamin Thuma — 12 Patents

Issued Patents All Time

Patent Widget